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DIFFERENTIATED THYROID CARCINOMAS ASSOCIATED 
WITH CHRONIC THYROIDITIS:  
BIOLOGICAL AND CLINICAL PROPERTIES
T.M. Myshunina*, B.D. Guda, M.Yu. Bolgov, N.I. Mikhailenko, N.D. Tronko
State Institution “V.P. Komisarenko Institute of Endocrinology and Metabolism of the National Academy 
of Medical Sciences of Ukraine”, Kyiv 04114, Ukraine
Aim: To determine biological and clinical features of papillary and follicular thyroid carcinomas associated or not associated with chronic 
thyroiditis. Materials and Methods: The study was conducted by retrospective analysis of medical histories of 2,459 patients with thyroid 
cancer. Tumor size, its category according to the TNM system, multi-focal properties of tumor growth, carcinoma invasiveness, as well 
as disease stage, rates of relapses and metastasis, and also cumulative survival rates were analyzed. Results: The tumor size in patients 
with papillary or follicular carcinoma associated with thyroiditis was smaller compared to the patients without thyroiditis. In the first 
case, the invasion frequency into extrathyroid structure and into the capsule was also lower. Multi-focal growth of both carcinoma 
types was registered more frequently in the presence of thyroiditis. The frequency of papillary carcinoma metastasis to lateral cervi-
cal lymph nodes was lower in the presence of thyroiditis, the frequency being equal for metastasis into lymph nodes of the VI lymph 
outflow zone in both groups of patients (with and without thyroiditis). In the presence of thyroiditis, the frequency of distant papillary 
carcinoma metastasis was decreased, no metastases were detected in patients with follicular carcinoma. In the group of patients with 
papillary carcinoma there was found no relation between the presence of thyroiditis and disease stage, relapse rates, and mortality 
levels; however, the risk of follicular carcinoma relapse was significantly lower in patients with thyroiditis. Conclusions: The presence 
of chronic thyroiditis in papillary carcinoma patients showed a certain positive impact on the course of the disease, in particular, 
primary tumor growth, invasion, and metastasis. Such effect is even more expressed in the patients with follicular thyroid carcinoma.
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Currently, there is no doubt regarding the intimate 
association between papillary carcinoma and chronic 
thyroiditis detected in extratumoral thyroid tissue [1–4]. 
At the same time, there is no consensus regarding 
a possible impact of autoimmune process on the 
prognosis in such patients [5, 6]. While some authors 
conclude on none relation between biological proper­
ties of papillary carcinomas and the disease course 
with the chronic thyroiditis presence [7–11], there are 
other opinions suggesting the concomitant thyroiditis 
to be a factor of more favorable disease course [12–15]. 
In contrary, some authors insist on negative influence 
of the chronic thyroiditis on papillary carcinoma course 
[16–18] dependent on the thyroiditis severity [19].
We have previously shown that the chronic thyroi­
ditis accompanies more frequently papillary carcinoma 
(these data are in agreement with the results obtained 
by the majority of authors); this condition is also often 
found in patients with follicular carcinomas and rarely 
in cases of anaplastic carcinomas [20]. The aim of this 
study was to determine the frequency of certain bio­
logical and clinical features inherent to papillary and 
follicular carcinomas in cases of chronic thyroiditis 
presence in extratumoral tissue.
MATERIALS AND METHODS
In this retrospective study, the medical records 
of patients who underwent surgical treatment of malig­
nant thyroid neoplasms in the Department of Surgery 
of the State Institution “V.P. Komisarenko Institute 
of Endocrinology and Metabolism, National Academy 
of Medical Sciences of Ukraine” in 2000–2015 were 
analyzed. We have analyzed the data of patients whose 
case histories included not only pathohistological 
examination of tumors, but also pathomorphological 
characterization of thyroid extratumoral tissue. The 
group of comparison (control group) included patients 
without any significant pathological changes in extra­
tumoral tissue surrounding papillary or follicular car­
cinoma. The cohort studied enrolled 2,459 patients. 
This study has been approved by Institute’s Committee 
on Biological & Medical Ethics.
The data analysis covers real tumor size, tumor 
category according to the TNM system, multifocal char­
acter of tumor growth, invasive properties of carcinoma 
as well as disease stage, presence of relapses, patients’ 
risk group, and cumulative survival level using Kaplan — 
Meyer method.
Data were analyzed statistically using χ2­test for 
comparison between groups. To compare the values 
of cumulative survival index between the groups, non­
parametric log­rank test was conducted. All the statis­
tical calculations were carried out using the software 
packet Statistica 12 by StatSoft, Inc. Differences were 
considered significant at p < 0.05.
RESULTS
The frequency of tumors with the size ≤ 1 cm was 
higher among patients with differentiated carcinomas 
accompanied with chronic thyroiditis in extratumoral tis­
sues, while the larger tumor size was found among such 
patients with lower frequency (Tables 1, 2). The significant 
changes regarding larger tumors are registered in the 
groups of patients with papillary carcinomas (21–40 mm) 
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and follicular cancer (> 40 mm), the significant difference 
being found for patients’ groups with follicular carcinomas.
Table 1. Сlinical characteristics of рapillary carcinoma cases 
with the presence or absence of chronic thyroiditis in extratumoral tissues
Index
Number of patients, n (%)
р
without  
thyroiditis
(n = 853)
with  
thyroiditis
(n = 1453)
Tumor size: < 10 mm 239 (28.0) 470 (32.3) 0.0296
11–20 mm 330 (38.7) 577 (39.7) 0.6269
21–40 mm 228 (26.7) 319 (22.0) 0.0092
> 40 mm 56 (6.6) 87 (6.0) 0.5788
Category: Т1 463 (54.3) 880 (60.6) 0.0031
Т2 141 (16.5) 221 (15.2) 0.4002
Т3 206 (24.2) 314 (21.6) 0.6343
Т4а 43 (5.0) 37 (2.5) 0.0015
Т4b 0 (0.0) 1 (0.1) 0.4434
N0 523 (61.3) 950 (65.4) 0.0495
N1а 135 (15.8) 221 (15.2) 0.6923
N1b 70 (8.2) 94 (6.5) 0.0479
N1ab 125 (14.6) 197 (13.6) 0.3817
М1 32 (3.8) 14 (1.0) 0.0000
Intrathyroid invasion 528 (61.9) 908 (62.5) 0.7769
Invasion into the gland cap-
sule
765 (89.7) 1333 (91.7) 0.3503
Extrathyroid invasion 207 (24.3) 300 (20.6) 0.0427
Multifocal growth 101 (11.8) 291 (20.0) 0.0000
Disease stage: І 708 (83.0) 1197 (82.4) 0.7045
ІІ 53 (6.2) 91 (6.3) 0.9621
ІІІ 52 (6.2) 99 (6.8) 0.7874
ІV 39 (4.6) 64 (4.4) 0.8509
Risk group: 1 173 (20.3) 299 (20.6) 0.8646
2 273 (32.0) 524 (36.1) 0.0478
3 407 (47.7) 630 (43.3) 0.0423
Relapses 29 (3.4) 45 (3.0) 0.6904
Mortality 3 (0.4) 6 (0.4) 0.8198
Table 2. Clinical characteristics of follicular carcinoma cases 
with the presence or absence of chronic thyroiditis in extratumoral tissues
Index
Number of patients, n (%)
р
without  
thyroiditis
(n = 65)
with  
thyroiditis
(n = 88)
Tumor size: < 10 mm 6 (9.2) 19 (21.6) 0.0409
11–20 mm 20 (30.8) 31 (35.2) 0.5631
21–40 mm 20 (30.8) 30 (34.1) 0.6650
> 40 mm 19 (29.2) 8 (9.1) 0.0012
Category: Т1 19 (29.2) 44 (50.0) 0.0098
Т2 19 (29.2) 26 (29.5) 0.9663
Т3 26 (40.0) 16 (18.2) 0.0027
Т4а 1 (1.6) 2 (2.3) 0.7532
Т4b 0 (0.0) 0 (0.0) –
М1 3 (4.6) 0 (0.0) 0.0418
Intrathyroid invasion 29 (44.6) 39 (43.2) 0.9701
Invasion into the gland capsule 61 (93.8) 73 (82.9) 0.0434
Extrathyroid invasion 8 (12.3) 11 (12.5) 0.8616
Multifocal growth 4 (6.1) 15 (17.0) 0.0434
Disease stage: І 54 (83.1) 60 (68.2) 0.0366
ІІ 2 (3.1) 11 (12.5) 0.0387
ІІІ 7 (10.7) 15 (17.0) 0.2741
ІV 2 (3.1) 2 (2.3) 0.7579
Risk group: 1 5 (7.7) 17 (19.3) 0.0427
2 30 (46.2) 47 (53.4) 0.3749
3 30 (46.2) 24 (27.2) 0.0157
Relapses 3 (4.6) 0 (0.0) 0.0418
Mortality 3 (4.6) 0 (0.0) 0.0418
Generally saying, such a situation was also observed 
regarding tumor properties according to the TNM sys­
tem: the relative patients’ quantity in the cohort with 
T1 category tumors was higher in cases of thyroiditis­
associated tumors while the quantity of patients with 
T4a papillary carcinomas and with T3 follicular cancer 
was lower (see Tables 1, 2).
Number of patients with papillary carcinoma of the 
N0 category was higher in the case of concomitant 
(associated) thyroiditis due to the lower number of N1b 
cases; this group included also lower number of pa­
tients with distant metastases. The latest was true also 
for patients with follicular carcinomas (see Tables 1, 2).
The analysis of invasive carcinoma properties de­
monstrated that the percent of patients with tumor inva­
sion into the gland parenchyma was the same in cases 
with or without thyroiditis; in cases of thyroiditis­asso­
ciated papillary carcinoma the percent was lower if the 
invasion was found out of the thyroid structure; in cases 
of thyroiditis­associated follicular carcinoma this percent 
was shown to be lower in the case of the invasion into the 
gland capsule. On the contrary, the multifocal growth 
of both papillary and follicular carcinomas was more often 
seen in patients with associated thyroiditis comparing 
to ones whose extratumoral tissues did not demonstrate 
concomitant pathological changes (see Tables 1, 2).
The distribution of papillary carcinoma patients ac­
cording to the disease stage did not detect a dependence 
on the chronic thyroiditis presence or absence, while 
a certain re­distribution was found between the groups 
of patients with follicular carcinomas: the concomitant 
thyroiditis was accompanied by higher percent of stage 
II cases and lower percent of patients with stage I. The 
part of follicular carcinoma patients belonging to the first 
risk group was higher due to the lower percent of patients 
belonging to the third risk group. Among patients with 
papillary carcinoma, such a re­distribution was found be­
tween patients of the second and third relapse risk group.
In patients group with chronic thyroiditis­associated 
follicular carcinomas, there were no cases with the 
disease relapse; also, there death cases were absent, 
although these indices reach about 5% among thyroiditis­
free patients (see Table 2). Among patients with papillary 
carcinomas, there were no differences in both relapse 
percent and mortality rates between the groups with and 
without thyroiditis (see Table 1). The cumulative survival 
level in patients with differentiated thyroid carcinomas did 
not differ between the groups with and without chronic 
thyroiditis in extratumoral tissues (Table 3).
Table 3. Cumulative survival of patients with differentiated thyroid car-
cinomas dependently on the presence or absence of chronic thyroiditis 
in extratumoral tissues
Term, years
Papillary carcinomas, % Follicular carcinomas, %
without 
thyroiditis
with 
thyroiditis
without 
thyroiditis
with 
thyroiditis
2 99.8 99.8 100.0 100.0
5 99.6 99.7 100.0 100.0
10 99.6 99.4 91.8 100.0
20 99.6 99.4 – –
р = 0.3812 р = 0.2358
DISCUSSION
In the available current scientific literature, there 
is an opinion that papillary carcinomas exert less ag­
gressive nature in cases of their association with chronic 
thyroiditis. It is manifested, firstly, by smaller tumor sizes 
as well as by less intensive lymph node metastasis and 
less intensive extrathyroid expansion [8, 13, 15, 21–24]. 
These conclusions are confirmed by our investigations, 
their results indicating the tumor sizes in chronic thyroid­
itis­associated papillary carcinomas to be really some­
what smaller comparing to cases without autoimmune 
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disease. The frequency of category T2–T4 tumors was 
also lower as well as the frequency of tumor invasion into 
extrathyroid structures (it is adequate to the decreased 
frequency of T4a category tumors being known as inva­
sive ones with marked penetration into sub­dermal soft 
tissues, larynx, trachea, and esophagus). Other authors’ 
reports indicate also the decreased tumor invasion into 
blood and lymph vessels [14]. On the contrary, the tumor 
invasion frequency into the gland parenchyma did not 
differ between patients’ groups with and without chronic 
thyroiditis (see Table 1), although in children and adoles­
cent cohort (108 persons) the thyroiditis presence was 
accompanied by almost double quantity of cases with 
intra­thyroid invasion [17]. Simultaneously, the frequency 
of cases with multi­focal papillary carcinoma growth was 
twice higher if chronic thyroiditis was present in the gland 
simultaneously with papillary carcinoma. These results 
coincide with the data of other investigators [4, 23] prov­
ing the more frequent multi­focal papillary carcinoma 
growth on the background of thyroiditis to confirm the 
opinion concerning the thyroiditis role in the carcino­
genesis initiation. It is even supposed that the thyroiditis 
shares a lot of features with carcinoma (morphological, 
immunohistochemical, and genetic ones) [27] to be, 
in essence, a microscopic carcinoma analogue [28].
According to our data, the frequency of papillary 
carcinoma metastases to lateral cervical lymph nodes 
(N1b) was lower in the presence of thyroiditis, metasta­
ses frequency into lymph nodes of the VІ zone of lymph 
outflow (N1а) being the same in patients with and without 
thyroi ditis. These data differ from the results obtained 
previously: in cases of thyroiditis, the metastases into the 
central compartment lymph nodes (the VІ zone) in thyroi­
ditis cases were rarer. This fact could be explained by pos­
sible protective role of autoimmune processes against the 
tumor expansion [4, 8, 12, 14], or, on the contrary, it occurs 
significantly more often [16]. The difference of metastases 
frequency into lateral lymph nodes in patients with multifo­
cal papillary carcinoma with or without thyroiditis was not 
significant [4, 12]. In some studies, no differences were 
found regarding tumor size, or TNM category, or meta­
stasis to cervical lymph nodes of thyroiditis­free patients 
with thyroid papillary carcinomas [9, 25].
It should be emphasized that the tumor size and 
metastasis rate depend on the presence of Ig4 immuno­
globulin subclass in the blood of patients with papillary 
carcinoma and thyroiditis, and these indexes are higher 
in IgG4­positive patients comparing with IgG4­negative 
ones [26]. Possibly, these new data concerning the dis­
tribution of patients with Hashimoto thyroiditis on IgG4­
positive and IgG4­negative ones may partly explain 
the contradictory results on the frequency of papillary 
carcinoma metastasis into lymph nodes of different 
neck regions in cases of autoimmune process. The 
presence of IgG4 subclass in patients’ blood may lead 
to worsened clinical consequences, although in general 
the thyroiditis is thought to be a positive prognostic 
factor for patients with papillary thyroid cancer [21].
There are certain differences shown for the frequency 
of described pathomorphological and clinical features 
of papillary carcinomas associated or not associated 
with thyroiditis. However, the patients distribution (taking 
also in consideration their age) between І–ІІІ diseases 
stages is the same, although there is a conclusion that the 
chronic thyroiditis may be associated with more favorable 
stage of tumor process [23]. Besides, it is also shown that 
the quantity of post­operational relapses in patients with 
papillary carcinoma associated with thyroiditis is lower 
than in thyroiditis­free cases, the prognosis being better 
in the first case [15, 21, 29]. According to our data, the 
relapse rates in the III high­risk group patients was lower 
in the subgroup with thyroiditis.
The data on the level of relapse­free cumulative sur­
vival are contradictory: in a cohort including 597 patients 
the survival was significantly higher in papillary carcinoma 
patients’ group with thyroiditis compared to thyroiditis­
free one [13], while in a cohort including 388 persons 
the authors did not find any statistically significant dif­
ference between the survival of patients with or without 
thyroiditis [23]. In the cohort examined in this study 
(2459 patients) both the mortality rates and the rates 
of relapse­free survival did not differ between the groups.
The analysis of thyroiditis impact on the thyroid fol­
licular carcinoma features is complicated, such studies 
are rare. It is ascertained that the chronic thyroiditis 
co­existence with follicular carcinoma is registered 
with lower frequency comparing to papillary cancer — 
in 0–20% of cases [6, 25, 29] and in 33% of cases 
in our study [20]. However, it is not known if such as­
sociation could have a significant impact on the course 
of the disease; it is also unknown if the pathologies 
possess any common molecular­biological, morpho­
logical, immuno­histochemical, or genetic properties.
Follicular and papillary tumors are known to possess 
a number of common properties allowing to suppose 
that thyroiditis may possibly have a similar impact on the 
properties of follicular carcinoma. However, contrary 
to papillary carcinomas, the follicular cancer is more 
aggressive, the prognosis being rather poor. The mean 
age of patients suffering from follicular carcinomas is ap­
proximately by 10 years higher compared to papillary 
carcinoma patients, their gender propensity being the 
same. For these differentiated carcinomas, the latent 
period for induction of carcinogenic transformation due 
to radioactive exposure is different [30, 31]; this fact may 
be associated with different types of genetic damages 
being found in cells of these carcinomas.
The tumor size of both follicular and papillary carcino­
mas was smaller in the cases of chronic thyroiditis. The 
significantly increase number of small tumors (< 10 mm) 
is due to three­fold decreased number of large neoplasms 
(> 40 mm) corresponding to the re­distribution of T1 and 
T3 category carcinomas; the latest fact was caused by the 
decreased percent of tumor invasion into the capsule. 
It should be noted the quantitative parameters of such 
re­distribution are similar to those of papillary carcinomas. 
No distant metastases were detected in the patients with 
thyroiditis­associated follicular carcinomas, these data 
being in agreement with other reports [29]. However, 
in cases of both papillary and follicular thyroiditis­associ­
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ated carcinomas, multifocal tumor growth was observed 
more often, especially in cases of follicular carcinomas.
Instead, in spite of certain “positive” features 
of chronic thyroiditis­associated follicular carcinomas, 
the percent of the I stage patients was lower in thyroiditis­
associated cases, the percent of the II stage cases be­
ing higher compared to thyroiditis­free patients; it may 
be due to older age of patients with thyroiditis [20]. 
However, the disease relapse risk (as well as the relapse 
rate) in patients with thyroiditis­associated follicular car­
cinomas was significantly lower compared to patients 
without thyroiditis. Of note, the survival rates in both 
groups of patients were similar without lethal outcomes 
in the group of patients with thyroiditis.
Thus, the presence of chronic thyroiditis in papillary 
carcinoma patients demonstrated a certain positive ef­
fect on the course of the disease, in particular, primary 
tumor growth, invasion, and metastasis. Such effect 
was even more expressed in the patients with thyroid 
follicular carcinoma, more aggressive thyroid cancer.
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